AYTU Aytu BioScience Inc

USD 2.75 -0.04 -1.308244
Icon

Aytu BioScience Inc (AYTU) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.75

-0.04 (-1.31)%

USD 0.02B

7.22K

N/A

N/A

Icon

AYTU

Aytu BioScience Inc (USD)
COMMON STOCK | NSD
USD 2.75
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 2.75

Aytu BioScience Inc (AYTU) Stock Forecast

N/A

Based on the Aytu BioScience Inc stock forecast from 0 analysts, the average analyst target price for Aytu BioScience Inc is not available over the next 12 months. Aytu BioScience Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aytu BioScience Inc is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Aytu BioScience Inc’s stock price was USD 2.75. Aytu BioScience Inc’s stock price has changed by -2.36% over the past week, -5.38% over the past month and +52.13% over the last year.

No recent analyst target price found for Aytu BioScience Inc
No recent average analyst rating found for Aytu BioScience Inc

Company Overview Aytu BioScience Inc

Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment...Read More

https://aytubio.com

373 Inverness Parkway, Englewood, CO, United States, 80112

150

June

USD

USA

Adjusted Closing Price for Aytu BioScience Inc (AYTU)

Loading...

Unadjusted Closing Price for Aytu BioScience Inc (AYTU)

Loading...

Share Trading Volume for Aytu BioScience Inc Shares

Loading...

Compare Performance of Aytu BioScience Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AYTU

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aytu BioScience Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NBIX
Neurocrine Biosciences Inc -0.41 (-0.28%) USD14.66B 39.48 36.15

ETFs Containing AYTU

Symbol Name AYTU's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aytu BioScience Inc (AYTU) Stock

Stock Target Advisor's fundamental analysis for Aytu BioScience Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on AYTU's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AYTU's stock to indicate what its average analyst target is.

AYTU stock's Price/Earning ratio is 0.01. Our analysis grades AYTU stock's Price / Earning ratio at A. This means that AYTU stock's Price/Earning ratio is above 4.000000000000004% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this AYTU may be undervalued for its sector.

The last closing price of AYTU's stock was USD 2.75.

The most recent market capitalization for AYTU is USD 0.02B.

Unfortunately we do not have enough analyst data on AYTU's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Aytu BioScience Inc's stock.

As per our most recent records Aytu BioScience Inc has 150 Employees.

Aytu BioScience Inc's registered address is 373 Inverness Parkway, Englewood, CO, United States, 80112. You can get more information about it from Aytu BioScience Inc's website at https://aytubio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...